Delivery Order SPE2DB20D9127-SPE2DB23FPQF5
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,383.04, is for the delivery of 120 tablets of the prescription drug Nexavar (sorafenib) 200 mg. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,781.49 contract is for the delivery of Nexavar 200 mg tablets to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,578.52, is for the delivery of Nexavar 200 mg tablets. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $19,157.04, is for the delivery of 4,558,650,871 units of the prescription drug Nexavar 200 mg tablet. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC enables...
- This is a firm fixed-price delivery order (SPE2DB23FPQB3) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $9,578.52 and has a completion date of February 28, 2023. The award is for the delivery of Nexavar 200 mg tablets. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $56,298.24 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 tablets of the prescription drug Nexavar 200 mg, with a period of performance through September 8, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $28,149.12 firm-fixed-price contract is for the delivery of 4,563,964 units of the pharmaceutical drug Nexavar 200 mg tablet in 120-count bottles. The contract has a period of performance through March 13, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract, valued at up to $4,999,999, with DLA for a broad range of...
- This award is a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Nexavar 200 mg tablets. The order is placed under a $499,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) for a wide range of pharmaceutical products to support military healthcare facilities. The delivery order has a ceiling value of $9,578.52 and an ultimate completion date of July 26, 2022. This award is...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $19,157.04 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,559,465,122 units of the prescription drug Nexavar 200 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a comprehensive range of branded and generic prescription...
- This federal contract award, valued at $13,781.49, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 120 units of the prescription drug Nexavar 200 mg tablet. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB23FPQF5Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,578.52 delivery order is for the supply of 120 tablets of the prescription drug Nexavar (sorafenib) 200 mg. The contract has an ultimate completion date of March 29, 2023 and was awarded on March 28, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities. This contract award does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal contracts across multiple product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 3/28/23 |